Silencing of MGMT with small interference RNA reversed resistance in human BCUN-resistant glioma cell lines

Chinese Medical Journal

Volumn 124, Issue 17, 2011, Pages 2605-2610

  Xie, Si Ming ^a   Fang, Mao ^a   Guo, Hui ^a   Zhong, Xue Yun ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

1,3 bis(2 chloroethyl) 1 nitrosourea; Drug resistance; Glioma; MGMT; Small interferencing RNA

Indexed keywords

CARMUSTINE; MESSENGER RNA; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; SMALL INTERFERING RNA;

ARTICLE; CANCER CELL CULTURE; CELL ASSAY; CONTROLLED STUDY; DRUG CYTOTOXICITY; GENE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE GENE; PHENOTYPE; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; WESTERN BLOTTING;

BLOTTING, WESTERN; CARMUSTINE; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; GLIOMA; HUMANS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; SINCALIDE;

EID: 80052552094     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.2011.17.008     Document Type: Article

References (26)

1. Kleihues P, Louis DN, Scheithauer BW, Rorkel LB, Reifenberger G, Burger PC, et al. The WHO classification of tumors of the nervous system. J Neuropathol Exp Neurol 2002; 61: 215-225.
2. Wen PY, Kesari S. Malignant gliomas in adults. N Engl J Med 2008; 359: 492-507.
3. Karacetin D, Okten B, Yalcin B, Incekara O. Concomitant temozolomide and radiotherapy versus radiotherapy alone for treatment of newly diagnosed glioblastoma multiforme. J BUON 2011; 16: 133-137.
4. Zhou YX, Huang YL. Antiangiogenic effect of celastrol on the growth of human glioma: an in vitro and in vivo study. Chin Med J 2009; 122: 1666-1673.
5. Sarkaria JN, Kitange GJ, James CD, Plummer R, Calvert H, Weller M, et al. Mechanisms of chemoresistance to alkylating agents in malignant glioma. Clin Cancer Res 2008; 14: 2900-2908.
6. Sciuscio D, Diserens AC, van Dommelen K, Martinet D, Jones G, Janzer RC, et al. Extent and patterns of MGMT promoter methylation in glioblastoma- and respective glioblastoma-derived spheres. Clin Cancer Res 2011; 17: 255-266.
7. Christmann M, Verbeek B, Roos WP, Kaina B. O(6)-Methylguanine-DNA methyltransferase (MGMT) in normal tissues and tumors: enzyme activity, promoter methylation and immunohistochemistry. Biochim Biophys Acta 2011; Epub ahead of print.
8. 6-methylguanine methyltransferase promoter hypermethylation following n-butylidenephthalide combined with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on inhibition of human hepatocellular carcinoma cell growth. J Agric Food Chem 2010; 58: 1630-1638.
9. 6-methylguanine DNA methyltransferase gene promoter methylation in high-grade gliomas: a review of current status. Neurol India 2011; 59: 229-235.
10. Bock HC, Puchner MJ, Lohmann F, Schütze M, Koll S, Ketter R, et al. First-line treatment of malignant glioma with carmustine implants followed by concomitant radiochemotherapy: a multicenter experience. Neurosurg Rev 2010; 33: 441-449.
11. 6-methylguanine-DNA-methyltransferase on mammalian cells. Chin Med J 2007; 120: 714-717.
12. Lin CL, Wang MH, Qin YF, Fang M, Xie BB, Zhong XY. Differentiation of SWO-38 glioma cells induced by CDA-2 is mediated by peroxisome proliferator-activated receptor γ. J Neurooncol 2009; 95: 29-36.
13. Shi LX, Ma R, Lu R, Xu Q, Zhu ZF, Wang L. Reversal effect of tyroservatide (YSV) tripeptide on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU. Cancer Lett 2008; 269: 101-110.
14. Zheng X, Shen G., Yang X, Liu W. Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 2007; 67: 3691-3697.
15. -ΔΔCtC(T)) method. Methods 2001; 25: 402-408.
16. Smith JL, Rangaraj K, Simpson R, Maclean DJ, Nathanson LK, Stuart KA. Quantitative analysis of the expression of ACAT genes in human tissues by real-time PCR. J Lipid Res 2004; 45: 686-696.
17. Liu L, Zhang Q, Zhang Y, Wang S, Ding Y. Lentivirus-mediated silencing of Tiam1 gene influences multiple functions of a human colorectal cancer cell line. Neoplasia 2006; 8: 917-924.
18. Liu LL, Gerson SL. Targeted modulation of MGMT: clinical implications. Clin Cancer Res 2006; 12: 328-331.
19. Bandres E, Andion E, Escalada A, Honorato B, Catalan V, Cubedo E, et al. Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol 2005; 73: 189-198.
20. Esteller M, Garcia-Foncillas J, Andion E, Goodman SN, Hidalgo OF, Vanaclocha V, et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 2000; 343: 1350-1354.
21. 6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. Cancer Invest 2010; 28: 331-339.
22. 6-methylguanine DNA-methyltransferase (MGMT) overexpression in melanoma cells induces resistance to nitrosoureas and temozolomide but sensitizes to mitomycin C. Toxicol Appl Pharm 2006; 211: 97-105.
23. 6-methylguanine-DNA methyltransferase. Am J Physiol Lung Cell Mol Physiol 2001; 280: L755-L761.
24. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for newly diagnosed glioblastoma. N Eng J Med 2005; 352: 987-996.
25. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 2005; 352: 997-1003.
26. Kato T, Natsume A, Toda H, Iwamizu H, Sugita T, Hachisu R. Efficient delivery of liposome-mediated MGMT-siRNA reinforces the cytotoxity of temozolomide in GBM-initiating cells. Gene Ther 2010; 17: 1363-1371.